Focus On Business: Sam Perkins on Ultraviolet Technology

WEKU | By Bryan Bartlett

Published January 30, 2017 at 9:00 AM EST

Tom Martin talks with Sam Perkins, CEO of Purgenix. The company produces ultraviolet technology to rid hospitals of the airborne pathogens responsible for antibiotic-resistant infections. The technology is now in use in the UK Medical Center surgical suite.

7FOB0130WEB.mp3

Part two of Tom Martin's conversation with Purgenix CEO Sam Perkins.

Related Content

NPR News

Most of President Trump's tariffs are illegal, U.S. court rules

Scott Horsley

The U.S. Court of Appeals for the Federal Circuit, in Washington, D.C., delayed enforcing its decision, which is expected to be appealed to the Supreme Court.
Trump's lesser-known conflicts

Franco Ordoñez

President Trump has been focusing on some of the lesser-known conflicts in the world as peace remains elusive for Ukraine and Gaza.
A surprise trade by the Dallas Cowboys has fans up in arms

For Dallas Cowboys fans, this year's season starts with a loss even before the first game.
New Colorado law lets health officials seek out non-CDC vaccine guidance

John Daley

As the federal government challenges years of established science on vaccine safety, Colorado passed a new law letting its health officials consult other experts instead of relying on CDC guidance.
Buying something from overseas? Today, it gets trickier

Juana Summers

NPR's Juana Summers talks with New York Times business reporter Peter Eavis about the end of the de minimis exemption for international shipments, and what it means for consumers.